Valuation Cizzle Biotechnology Holdings Plc
Equities
CIZ
GB00BNG2VN02
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.450 GBX | 0.00% |
|
+3.57% | -6.45% |
| 05/11 | Cizzle Biotechnology Raises Funds via Convertible Loan Note Issue | MT |
| 05/11 | Cizzle Biotechnology announces LOI with leading UK clinical diagnostic group | RE |
Company Valuation: Cizzle Biotechnology Holdings Plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Capitalization 1 | 7.603 | 5.034 | 7.095 | 6.144 |
| Change | - | -33.79% | 40.94% | -13.4% |
| Enterprise Value (EV) 1 | 6.728 | 4.556 | 5.538 | 5.757 |
| Change | - | -32.29% | 21.55% | 3.96% |
| P/E ratio | -1.23x | -4.63x | -4.04x | -2.77x |
| PBR | 8.11x | 1.87x | 4.71x | 75.2x |
| PEG | 0.1x | 0.1x | -0.1x | -0.2x |
| Capitalization / Revenue | - | - | - | - |
| EV / Revenue | - | - | - | - |
| EV / EBITDA | - | - | - | - |
| EV / EBIT | -8.43x | -4.73x | -5.67x | -6.57x |
| EV / FCF | 2.58x | -6.76x | -32.4x | -55.6x |
| FCF Yield | 38.7% | -14.8% | -3.09% | -1.8% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -0.0244 | -0.00313 | -0.004824 | -0.00559 |
| Distribution rate | - | - | - | - |
| Net sales | - | - | - | - |
| EBITDA 1 | - | - | - | - |
| EBIT 1 | -0.798 | -0.963 | -0.976 | -0.876 |
| Net income 1 | -3.921 | -0.912 | -1.717 | -2.166 |
| Net Debt 1 | -0.875 | -0.478 | -1.557 | -0.387 |
| Reference price 2 | 0.0300 | 0.0145 | 0.0195 | 0.0155 |
| Nbr of stocks (in thousands) | 2,53,448 | 3,47,175 | 3,63,842 | 3,96,392 |
| Announcement Date | 21/06/22 | 27/04/23 | 30/04/24 | 30/04/25 |
1GBP in Million2GBP
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 77.39L | ||
| 37.79x | 5.5x | 18.4x | 0.9% | 4.83TCr | ||
| 32.91x | 3.28x | 14.06x | -.--% | 3.98TCr | ||
| 102.27x | 6.54x | 65.78x | -.--% | 3.7TCr | ||
| 54.65x | 11.21x | 31.16x | 0.35% | 3.07TCr | ||
| -20.8x | 6035.16x | -19.72x | -.--% | 2.25TCr | ||
| 40.7x | 6.6x | 29.98x | -.--% | 1.7TCr | ||
| Average | 41.25x | 1,011.38x | 23.28x | 0.21% | 2.79TCr | |
| Weighted average by Cap. | 45.17x | 700.12x | 25.12x | 0.28% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- CIZ Stock
- Valuation Cizzle Biotechnology Holdings Plc
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















